Literature DB >> 25250200

Kinetic modeling in PET imaging of hypoxia.

Fan Li1, Jesper T Joergensen1, Anders E Hansen2, Andreas Kjaer1.   

Abstract

Tumor hypoxia is associated with increased therapeutic resistance leading to poor treatment outcome. Therefore the ability to detect and quantify intratumoral oxygenation could play an important role in future individual personalized treatment strategies. Positron Emission Tomography (PET) can be used for non-invasive mapping of tissue oxygenation in vivo and several hypoxia specific PET tracers have been developed. Evaluation of PET data in the clinic is commonly based on visual assessment together with semiquantitative measurements e.g. standard uptake value (SUV). However, dynamic PET contains additional valuable information on the temporal changes in tracer distribution. Kinetic modeling can be used to extract relevant pharmacokinetic parameters of tracer behavior in vivo that reflects relevant physiological processes. In this paper, we review the potential contribution of kinetic analysis for PET imaging of hypoxia.

Entities:  

Keywords:  18F-FAZA; 18F-FETNIM; 18F-FMISO; Cu-ATSM; oxygenation

Year:  2014        PMID: 25250200      PMCID: PMC4171837     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  115 in total

1.  Performance evaluation of kinetic parameter estimation methods in dynamic FDG-PET studies.

Authors:  Xiaoqian Dai; Zhe Chen; Jie Tian
Journal:  Nucl Med Commun       Date:  2011-01       Impact factor: 1.690

Review 2.  Image-derived input function for brain PET studies: many challenges and few opportunities.

Authors:  Paolo Zanotti-Fregonara; Kewei Chen; Jeih-San Liow; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-03       Impact factor: 6.200

3.  Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Authors:  Eline E Verwer; Floris H P van Velden; Idris Bahce; Maqsood Yaqub; Robert C Schuit; Albert D Windhorst; Pieter Raijmakers; Adriaan A Lammertsma; Egbert F Smit; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

4.  Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Authors:  Morand Piert; Hans-Jürgen Machulla; Maria Picchio; Gerald Reischl; Sybille Ziegler; Piyush Kumar; Hans-Jürgen Wester; Roswitha Beck; Alexander J B McEwan; Leonard I Wiebe; Markus Schwaiger
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

5.  Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.

Authors:  Ly-Binh-An Tran; Anne Bol; Daniel Labar; Bénédicte Jordan; Julie Magat; Lionel Mignion; Vincent Grégoire; Bernard Gallez
Journal:  Radiother Oncol       Date:  2012-06-06       Impact factor: 6.280

6.  pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.

Authors:  Bernd Gagel; Patrick Reinartz; Ercole Dimartino; Michael Zimny; Michael Pinkawa; Payam Maneschi; Sven Stanzel; Kurt Hamacher; Heinz H Coenen; Michael Westhofen; Ulrich Büll; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2004-10       Impact factor: 3.621

7.  Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Authors:  HyungJoon Cho; Ellen Ackerstaff; Sean Carlin; Mihaela E Lupu; Ya Wang; Asif Rizwan; Joseph O'Donoghue; C Clifton Ling; John L Humm; Pat B Zanzonico; Jason A Koutcher
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

8.  A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

Authors:  J J Casciari; M M Graham; J S Rasey
Journal:  Med Phys       Date:  1995-07       Impact factor: 4.071

9.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Authors:  Daniela Thorwarth; Susanne-Martina Eschmann; Jutta Scheiderbauer; Frank Paulsen; Markus Alber
Journal:  BMC Cancer       Date:  2005-12-01       Impact factor: 4.430

10.  A marker for hypoxic cells in tumours with potential clinical applicability.

Authors:  J D Chapman; A J Franko; J Sharplin
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

View more
  14 in total

1.  Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.

Authors:  Olivia J Kelada; Sara Rockwell; Ming-Qiang Zheng; Yiyun Huang; Yanfeng Liu; Carmen J Booth; Roy H Decker; Uwe Oelfke; Richard E Carson; David J Carlson
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

Review 2.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; Meenakshi H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

3.  Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value.

Authors:  Maria Elisa Serrano; Mohamed Ali Bahri; Guillaume Becker; Alain Seret; Frédéric Mievis; Fabrice Giacomelli; Christian Lemaire; Eric Salmon; André Luxen; Alain Plenevaux
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

Review 4.  Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Authors:  Sonja Stieb; Afroditi Eleftheriou; Geoffrey Warnock; Matthias Guckenberger; Oliver Riesterer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-20       Impact factor: 9.236

5.  Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.

Authors:  Jazmin Schwartz; Milan Grkovski; Andreas Rimner; Heiko Schöder; Pat B Zanzonico; Sean D Carlin; Kevin D Staton; John L Humm; Sadek A Nehmeh
Journal:  J Nucl Med       Date:  2017-02-23       Impact factor: 10.057

6.  Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.

Authors:  Pamela Mena-Romano; Caixia Cheng; Christin Glowa; Peter Peschke; Leyun Pan; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss; Christian P Karger
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

7.  Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice.

Authors:  Fan Li; Jesper Tranekjær Jørgensen; Jacob Madsen; Andreas Kjaer
Journal:  Diagnostics (Basel)       Date:  2015-03-27

8.  18 F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.

Authors:  Daniel R McGowan; Ruth E Macpherson; Sara L Hackett; Dan Liu; Fergus V Gleeson; W Gillies McKenna; Geoff S Higgins; John D Fenwick
Journal:  Med Phys       Date:  2017-07-21       Impact factor: 4.071

Review 9.  Hypoxia imaging and radiotherapy: bridging the resolution gap.

Authors:  David Robert Grimes; Daniel R Warren; Samantha Warren
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

10.  Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.

Authors:  Naoyuki Ukon; Songji Zhao; Wenwen Yu; Yoichi Shimizu; Ken-Ichi Nishijima; Naoki Kubo; Yoshimasa Kitagawa; Nagara Tamaki; Kei Higashikawa; Hironobu Yasui; Yuji Kuge
Journal:  EJNMMI Res       Date:  2016-12-12       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.